# Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas

> **NCT00689715** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Cystic Tumors of the Pancreas

## Interventions

- **PROCEDURE:** Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection

## Key facts

- **NCT ID:** NCT00689715
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-06
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2016-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00689715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00689715, "Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00689715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*